Back
America Movil SAB de CV Vs. Blueprint Medicines Industry Stock Comparison
Buy
51
AMX
America Movil SAB de CV
Last Price:
$18.35
Seasonality Move:
-0.96%
Buy
53
BPMC
Blueprint Medicines
Last Price:
$129.46
Seasonality Move:
1.87%
Buy
51
America Movil SAB de CV (AMX)
is a Buy
Is America Movil SAB de CV a Buy, Sell or Hold?
-
The current America Movil SAB de CV [AMX] share price is $18.34. The Score for AMX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
AMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AMX Stock Price Chart
What is America Movil SAB de CV's stock price today?
-
The America Movil SAB de CV share price today is $18.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $129.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
AMX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 65.55 | Buy |
Chaikin Money Flow: | 2198544 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.17 - 17.93) | Buy |
Bollinger Bands (100): | (14.88 - 17.74) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.06 | Buy |
Relative Strength Index (14 RSI): | 76.66 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.2 - 129.34) | Buy |
Bollinger Bands (100): | (86.6 - 123.96) | Buy |
AMX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.46 | Buy |
20-day SMA: | 17.65 | Buy |
50-day SMA: | 17.39 | Buy |
200-day SMA: | 15.67 | Buy |
8-day EMA: | 17.63 | Buy |
20-day EMA: | 17.54 | Buy |
50-day EMA: | 17.23 | Buy |
200-day EMA: | 16.37 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.42 | Buy |
20-day SMA: | 128.9 | Buy |
50-day SMA: | 121.21 | Buy |
200-day SMA: | 100.42 | Buy |
8-day EMA: | 129.37 | Buy |
20-day EMA: | 128.3 | Buy |
50-day EMA: | 121.15 | Buy |
200-day EMA: | 104.48 | Buy |
America Movil SAB de CV Earnings Growth & AMX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.01 per share, an increase this year of $0.85 per share, and an increase next year of $0.11 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.48 per share, an increase this year of $0.60 per share, and an increase next year of $1.59 per share.
America Movil SAB de CV Technical Analysis
Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |